LOVE Stock

In an April 6 initiation report, Haywood analyst Neal Gilmer launched coverage of Cannara Biotech (C... Read More

Research Capital analyst Andre Greg McLeish reiterated a “Buy” rating and $3.50 price target on ... Read More

Research Capital analyst Greg McLeish said in a July 29 update that Cannara Biotech (Cannara Biotech... Read More